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Abstract
Background: Hospital discharge codes are often used to determine the incidence of gestational diabetes mellitus
(GDM) at state and national levels. Previous studies demonstrate substantial variability in the accuracy of GDM
reporting, and rarely report how the GDM was diagnosed. Our aim was to identify deliveries coded as gestational
diabetes, and then to determine how the diagnosis was assigned and whether the diagnosis followed established
guidelines.
Methods: We identified which deliveries were coded at discharge as complicated by GDM at the Brigham and
Women’s Hospital in Boston, MA for the year 2010. We reviewed medical records to determine whether the codes
were appropriately assigned.
Results: Of 7883 deliveries, coding for GDM was assigned with 98% accuracy. We identified 362 cases assigned
GDM delivery codes, of which 210 (58%) had oral glucose tolerance test (OGTT) results available meeting
established criteria. We determined that 126 cases (34%) received a GDM delivery code due to a clinician diagnosis
documented in the medical record, without an OGTT result meeting established guidelines for GDM diagnosis. We
identified only 15 cases (4%) that were coding errors.
Conclusions: Thirty four percent of women assigned GDM delivery codes at discharge had a medical record
diagnosis of GDM but did not meet OGTT criteria for GDM by established guidelines. Although many of these
patients may have met guidelines if guideline-based testing had been conducted, our findings suggest that
clinician diagnosis outside of published guidelines may be common. There are many ramifications of this approach
to diagnosis, including affecting population-level statistics of GDM prevalence and the potential impact on some
women who may be diagnosed with GDM erroneously.
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Background
Hospital discharge data are commonly used to estimate
the prevalence of pregnancy complications including
gestational diabetes mellitus (GDM). These prevalence
data have the potential for far-reaching impact, since
they are often used at local and national levels to influ-
ence maternal and child health programs, monitor
trends, and determine allocation of resources [1]. There-
fore, understanding the patterns by which GDM diagno-
ses are given is important. Previous studies demonstrate
variable accuracy for the diagnosis of GDM during preg-
nancy as reported by hospital discharge data [2–4]. Of
note, many studies use documentation of GDM in the
medical record as the “gold standard,” but few studies
have examined how the GDM diagnosis was made [5, 6].
In 2010, the obstetric services at the Brigham and
Women’s Hospital (BWH) were using the American
College of Obstetricians and Gynecologists (ACOG) cri-
teria to diagnose GDM. These criteria were first estab-
lished in 2001 and then reaffirmed in 2013 [7, 8]. These
guidelines recommend that all pregnant women be
screened for diabetes with a 50-g glucose load test
(GLT) between 24 and 28 weeks of gestation. The rec-
ommendations state that women with a GLT result of
130 or 140 mg/dL (7.2 or 7.8 mmol/L) or greater should
undergo a three hour 100-g oral glucose tolerance test
(OGTT), with a diagnosis of GDM given for two or
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more abnormal values based on Carpenter-Coustan cri-
teria [7, 9]. The degree to which GDM diagnosis is made
outside of these published guidelines has not been quan-
tified nor well-described, yet may have significant impact
on the integrity of reported data. We therefore sought to
validate the hospital discharge diagnosis of GDM by
comparing it to the medical record diagnosis of GDM.
We then compared the medical record diagnosis to
ACOG criteria to determine whether the diagnosis of
GDM was made according to established guidelines.
Methods
The BWH is the largest obstetrical service in New Eng-
land with over 6000 deliveries per year, and approxi-
mately 5% of these pregnancies are complicated by
GDM. In 2010, at discharge, a delivery complicated by
GDM was assigned codes 648.80 (Diabetes mellitus of
mother complicating pregnancy childbirth or the puer-
perium unspecified as to episode of care), 648.81 (Dia-
betes mellitus of mother with delivery) and/or 648.83
(Antepartum diabetes mellitus), according to the Inter-
national Classification of Diseases, Ninth Revision (ICD-
9). We used the Research Patient Data Registry (RPDR),
a centralized database that houses clinical data from pa-
tient medical records within the Partners Healthcare sys-
tem, to obtain lists of patients discharged between
January 1, 2010 and December 31, 2010 with at least
one of the ICD-9 discharge codes associated with a diag-
nosis of GDM. In addition, we obtained a case list of all
women discharged with at least one of the ICD-9 codes
associated with a diagnosis of type 1 diabetes or type 2
diabetes (ICD-9 codes 648 and 250) so that we could
check for any deliveries to women with GDM that may
have been miscoded. We then used the RPDR to obtain
a separate list for lab values of all 3-h OGTTs performed
at BWH between March 1, 2009 and December 31,
2010. Since the 3-h OGTT test is used only during preg-
nancy to diagnose GDM, identifying these tests enabled
us to create an additional case list to compare with the
other lists. The institutional review board at BWH ap-
proved this project and a waiver of consent was received
from the Partners Human Research Committee to con-
duct the medical record review.
Once we identified cases of potential GDM either by
ICD-9 delivery code or by laboratory results, we
reviewed medical records to obtain age, race, parity, his-
tory of prior GDM, use of insulin during pregnancy,
mode of delivery, gestational age at delivery, pre-
pregnancy body mass index (BMI), and infant birth
weight, as well as results of GLT and OGTT testing. For
cases where laboratory results for the GLT or OGTT
were not available within the BWH system, we reviewed
results in clinic notes and outside laboratory reports
when available.
Once we obtained all of the ICD-9 coded cases as well
as all available GLT and OGTT values, we compared the
laboratory values to the Carpenter-Coustan ACOG
guidelines [8, 9]. We then placed cases into one of five
categories: 1) diagnosed by guidelines, 2) diagnosed out-
side of guidelines, 3) clinician error, 4) coding error, or
5) no laboratory values available (Table 1). A case met
the criteria for diagnosis by guidelines if the 3-h OGTT
had at least two abnormal values based on the
Carpenter-Coustan thresholds and the GDM ICD-9 code
was properly assigned. If the pre-pregnancy or first tri-
mester HbA1c met criteria for type 2 diabetes, we con-
sidered these cases to have preexisting diabetes and
therefore defined as a clinician error. For cases not
meeting the Carpenter-Coustan laboratory criteria, we
reviewed the medical record to determine whether and
how a clinician made a diagnosis of GDM. A case quali-
fied as “GDM diagnosed outside of guidelines” if the la-
boratory results in the medical record did not meet
criteria, but the clinician provided treatment for GDM,
including a prescribed diet, oral medication, and/or insu-
lin. Two physicians independently reviewed the cases
not meeting diagnosis criteria by guidelines, as well as
the records of cases assigned ICD-9 codes for T1DM (n
= 13) or T2DM (n = 29) to ensure that none of these
cases should have been coded as GDM deliveries.
We compiled descriptive tables of cases in the five dif-
ferent categories, and then compared those GDM cases
diagnosed by guidelines with those diagnosed outside of
guidelines using univariate and multivariate analyses to
determine predictors of diagnosis outside of guidelines,
using a significance level of p < .05. Univariate analyses
included t-tests, chi-squared tests, Fisher’s Exact tests,
and Wilcoxon tests, as appropriate. Multivariable logistic
regression analyses using variables with p values less
than .20 were also performed. Analyses were conducted
using JMP 10 Pro.
Results
Out of 7883 total deliveries, 362 (4.6%) cases of GDM
were identified by ICD-9 discharge coding (Fig. 1). We
validated 210 cases (57% of all GDM cases) as appropri-
ately coded and as diagnosed within guidelines based on
laboratory values meeting Carpenter-Coustan criteria.
An additional 126 GDM cases (34%) were diagnosed
outside of guidelines. Three of these cases were deter-
mined to be clinician error. In these cases, the GDM
code was assigned appropriately by the coders since the
diagnosis was clearly specified in the medical record;
however the GDM was incorrectly diagnosed by the
clinician. In addition, we identified 9 cases (0.1% of all
deliveries) where the OGTT met criteria but the ICD-9
delivery code for GDM was not assigned. We identified
6 cases (0.08% of all deliveries) where a GDM diagnosis
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was assigned but either there were no laboratory data
meeting criteria, or the patient had documented Type 2
diabetes. There were 20 cases (5.5% of GDM discharge
codes) where laboratory data were unavailable from the
medical record and we could not assess the validity of
the assigned delivery code. All deliveries coded as type 1
diabetes and type 2 diabetes were appropriately assigned.
As noted, clinical diagnosis of GDM outside of pub-
lished guidelines was common (N = 126, 34% of GDM
cases). There were multiple reasons for clinicians to
diagnose women with GDM outside guidelines (Fig. 1).
Of the 126 cases diagnosed outside of guidelines, 101
had some form of glucose tolerance testing (80%). An el-
evated GLT value alone led to diagnosis of GDM in 47
cases (37%), of which 28 (22%) of these cases had a GLT
result ≥ 200 mg/dL (11.1 mmol/L). Nineteen of the 126
(15%) were treated as GDM due to an elevated GLT and
only one abnormal value on the OGTT. In 25 cases no
glucose tolerance testing was performed. Twelve of these
women had a history of GDM and the clinician initiated
treatment without any formal glucose testing.
Characteristics of the cases diagnosed by guidelines
and the cases diagnosed outside guidelines are shown in
Table 2. Age, race, and pregnancy outcomes did not dif-
fer significantly between the two groups. Women diag-
nosed by guidelines were more likely to be nulliparous
(N = 108, 51%) than those diagnosed outside of guide-
lines (N = 40, 32%, P = .0004). Similarly, women diag-
nosed by guidelines were less likely to have a history of
GDM than women diagnosed outside of guidelines (N =
31 (15%) vs. 57 (45%), P < .0001). Among the 88 women
with a history of GDM, only 31 (35%) were diagnosed by
guidelines (as compared to 57% overall). In a logistic re-
gression analysis, a history of GDM led to 4.7 (95% CI
2.8–7.9) increased odds of a diagnosis outside of guide-
lines. Insulin use was not retained in the multivariable
model and nulliparity was removed from the model due
to collinearity with “history of GDM.”
Discussion
In this study, we validated cases of deliveries assigned
ICD-9 GDM discharge codes and found that 356/362
(98%) of cases assigned a GDM ICD-9 discharge code
had GDM specified in the medical record. We identified
only nine cases of deliveries with laboratory tests meet-
ing criteria for GDM that should have been assigned a
GDM ICD-9 code that were not. Of interest, we noted a
large proportion of the GDM cases (34%) were diag-
nosed outside of established clinical guidelines. A history
of GDM in a previous pregnancy demonstrated in-
creased odds for a diagnosis outside of guidelines.
The high rate of accuracy (98%) seen in our study for
GDM delivery codes may be in part due to the fact that
GDM codes were assigned based on a thorough review
of the medical record by experienced coders. In com-
parison, a medical record review study of deliveries in
Washington State reported a true positive rate for GDM
delivery discharge codes of 81% when compared to a re-
view of the medical record [2]. In a medical record re-
view study conducted among high volume hospitals in
California, the sensitivity was 78% for GDM ICD-9
codes when compared to a review of the medical record
[4].
In our study, we explored the way in which women
were given a diagnosis of GDM and notably one-third of
the GDM cases were diagnosed outside of established
clinical guidelines. Of these, more than half had some
abnormality in their GLT and/or OGTT, including 22%
with a GLT greater than or equal to 200 mg/dl. Many of
these women may have met criteria if guideline-based
diagnosis had been conducted. However, a previous
study revealed that, even with a cut-off of greater than
or equal to 200 mg/dl on the 50 g GLT, the likelihood of
GDM on a 3-h OGTT was only 69% [10]. Assigning a
diagnosis of GDM to women with lesser degrees of glu-
cose intolerance may reflect the clinician’s belief that
these women would benefit from treatment. In the ob-
servational Hyperglycemia and Adverse Pregnancy Out-
comes study, women with hyperglycemia not meeting
criteria for GDM were still at increased odds of multiple
adverse outcomes, including large-for-gestational-age
(LGA) birthweight, high cord-blood serum C-peptide
levels, primary cesarean delivery, neonatal hypoglycemia,








Clinician treated pregnancy as GDM due to one
or more of the following:
-GLT≥ 200 mg/dL (11.1 mmol/L)
-History of GDM or IFG or IGT
-1 abnormal value on OGTT
-Elevated fingersticks
-Inability to tolerate GLT or OGTT
-Elevated lab value (HbA1c, fasting or random
blood glucose)
Clinician error -Clinician misread OGTT results
-Type 2 DM called GDM
Coding error ICD-9 code assigned and no mention of GDM
diagnosis or treatment in prenatal care notes,
delivery admission, anesthesia record, or
discharge summary
OR 3 h OGTT ≥2 abnormal values with GDM
diagnosis in chart and no ICD-9 code assigned
No laboratory values
available
Transferred to BWH with GDM diagnosis and no
laboratory values or provider mentioned test
done but no values available
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premature delivery, shoulder dystocia or birth injury, in-
tensive neonatal care, hyperbilirubinemia, and pre-
eclampsia [11]. Despite the compelling observational
data however, there is still no clear evidence that treat-
ment of women with these milder glucose abnormalities
will decrease rates of complications [12]. For this reason,
at the time of the study and to date, the BWH has
elected to use two-step testing for the diagnosis of GDM
following Carpenter-Coustan criteria.
Diagnosis of GDM outside of guidelines may lead to
falsely inflated estimates of recurrence risk, and also in-
crease variability of administrative datasets. Conse-
quently, the overall reliability of these datasets is
decreased and may affect public health efforts and fund
allocation. In addition, a diagnosis of GDM has many
ramifications for women, including the need for frequent
fingersticks, dietary restriction, a more medicalized preg-
nancy, and possibly increased psychological distress [13,
14]. Some studies suggest that just carrying a diagnosis
of GDM increases the rate of cesarean delivery [8, 15,
16]. In addition, over-diagnosis of GDM is associated
with system-wide costs. A pregnancy affected by GDM
has an 18–34% increased cost over a normal pregnancy,
at an average of $3305, an annual cost of $636 million
[17].
An important finding in our study is that a history of
GDM in a prior pregnancy was significantly associated
with clinicians making a diagnosis of GDM without an
OGTT meeting criteria by guidelines or sometimes
without performing glucose tolerance testing at all. The
tendency not to formally retest women with prior GDM
may have a major impact on the estimates of recurrence
of GDM as many studies of recurrence rates use a dis-
charge diagnosis of GDM as the documentation for re-
currence. Estimates of the rates of recurrence of GDM
in a subsequent pregnancy are estimated at 41% from
large population studies, with a broader range of 30-84%
seen in studies of smaller populations [18, 19]. A recent
Fig. 1 Patterns of gestational diabetes diagnoses for deliveries at Brigham and Women’s Hospital in 2010. OGTT =Oral Glucose Tolerance Test;
GDM=Gestational Diabetes Mellitus; ICD-9 = International Classification of Diseases, Ninth Revision; GLT = Glucose Load Test (50-g); T2DM= Type 2
Diabetes Mellitus; WNL =Within Normal Limits; FS = fingersticks; FBG = fasting blood glucose; IFG = Impaired Fasting Glucose; IGT = Impaired Glucose
Tolerance; HbA1c = glycated hemoglobin
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report of recurrent GDM in Massachusetts looked at re-
current GDM using both discharge diagnosis and birth
certificate data found similarly high rates of recurrence
whether by birth certificate alone (38%), discharge diag-
nosis alone (47%) or the combination (48%). Import-
antly, however, the authors did not evaluate OGTT data
[20]. Our study provides important insight into the data
on the recurrence of GDM by documenting that at our
institution only 35% of women with a history of GDM
given a discharge diagnosis of GDM were diagnosed by
an OGTT meeting criteria in established guidelines.
Our findings must be interpreted in the context of
study design. We may not have identified all cases that
should have been coded as GDM but were not, espe-
cially if no laboratory data were found in our system.
This was a single institution study, and the coding and
clinician diagnosis patterns we identified may not be
representative of patterns at other hospitals.
Future studies should address the prevalence of GDM
diagnosis outside of established guidelines in other set-
tings, including community hospitals in addition to aca-
demic centers. Given recent controversy about new
diagnostic guidelines for GDM [21], it is important to
note that a large proportion of diagnoses may be made
outside of guidelines. Estimates of the impact of the new
guidelines on increasing the diagnosis of GDM [21] may
substantially underestimate the true impact of more lib-
eral guidelines on the incidence of GDM if clinical diag-
nosis outside of guidelines continues to occur. It may be
important to clarify clinical coding rules and diagnosis
guidelines in conjunction with the implementation of
new criteria, particularly if clinicians are using their own
judgment about when to apply guideline criteria. In
addition, public health agencies that use ICD discharge
data to estimate state and national incidence should be
aware of the potential contribution of clinician diagnosis
to those women receiving a chart diagnosis of GDM and
therefore an ICD code of GDM.
Conclusions
In this study, 98% of deliveries assigned ICD-9 gesta-
tional diabetes (GDM) discharge codes did have a diag-
nosis of GDM specified in the medical record. However,
34% of women assigned GDM delivery codes at dis-
charge did not meet OGTT criteria for GDM by estab-
lished guidelines. Although many of these patients may
have met guidelines if guideline-based testing had been
conducted, our findings suggest that clinician diagnosis
outside of published guidelines may be common. There
are many ramifications of this approach to diagnosis, in-
cluding affecting population-level statistics of GDM
prevalence and recurrence, as well as the potential im-
pact on some women who may be diagnosed with GDM
erroneously.
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Table 2 Comparison of cases diagnosed by guidelines versus cases diagnosed outside of guidelines
Characteristic Diagnosed by guidelines
(n = 210)
Diagnosed outside of guidelines
(n = 126)
P value for univariate analysis
Age in years, mean (SD) 34 (5) 34 (5) 0.69
Nulliparous, N (% of category) 108 (51%) 40 (32%) 0.0004
Race, N (% of category)
Hispanic 42 (20%) 19 (15%) 0.30
Black 42 (20%) 26 (21%) 0.89
Asian 32 (15%) 26 (21%) 0.23
White 79 (38%) 51 (40%) 0.72
Other/not reported 15 (7%) 4 (3%)
Prior GDM, N (% of category) 31 (15%) 57 (45%) <.0001
Pre-pregnancy BMI kg/m2, median (25th%ile; 75th%ile)
(n = 313)
27.5 (24, 33) 26.6 (24, 34) 0.82
BMI at delivery kg/m2, median (25th%ile; 75th%ile) (n=336) 32.6 (28, 37) 31.8 (29, 38) 0.70
Pregnancy outcomes:
Required insulin, N (% of category) 111 (53%) 78 (62%) 0.11
C-section, N (% of category) 92 (44%) 59 (47%) 0.59
Gestational age at delivery in weeks median
(25th%ile; 75th%ile)
39 (37, 39) 38 (37, 39) 0.26
Infant birth weight gm, mean (SD) 3210 (661) 3209 (789) 0.96
Nicklas et al. BMC Pregnancy and Childbirth  (2017) 17:11 Page 5 of 6
Funding
This study was supported by the Centers for Disease Control (CDC 200-2011-
M-3918), and work by the investigators was supported by an Institutional Na-
tional Research Service Award #T32AT000051 from the National Center for
Complementary and Alternative Medicine (NCCAM) at the National Institutes
of Health, an NIH BIRCWH K12 HD057022, an NIH NHLBI 1K23HL133604-01,
and a K24 from the National Heart Lung and Blood Institute at the National
Institutes of Health (9K24HL096141). We acknowledge the contribution from
program officers at the Centers for Disease Control who provided
conceptualization of ideas, interpreted findings, and review drafts of the
manuscript. However, the findings and conclusions are those of the authors
and do not necessarily represent the official position of the Centers for Dis-
ease Control and Prevention.
Availability of data and materials
The data will not be shared due to the presence of protected health
information.
Authors’ contributions
Dr. Nicklas takes responsibility for the integrity of the data and the accuracy
of the data analysis. J.N., J.L., and E.S. had full access to the data. J.N. and J.L.
wrote the manuscript. J.N., C.Z., J.L., and E.S. researched data and reviewed
and edited the manuscript. J.N. conducted the statistical analysis. All authors
read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
The Institutional Review Board at Brigham and Women’s Hospital approved
this project and a waiver of consent was received from the Partners Human
Research Committee to conduct the medical record review.
Author details
1Division of General Internal Medicine, University of Colorado School of
Medicine, 12348 E. Montview Blvd, C263, Aurora, CO 80045, USA. 2Division of
Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Brigham
and Women’s Hospital, Harvard Medical School, 75 Francis Street, Boston, MA
02115, USA. 3Division of Endocrinology, Diabetes and Hypertension, Brigham
and Women’s Hospital, Harvard Medical School, 221 Longwood Avenue,
Boston, MA 02115, USA.
Received: 25 March 2016 Accepted: 9 December 2016
References
1. Gillespie P, Cullinan J, O’Neill C, Dunne F. Modeling the independent effects
of gestational diabetes mellitus on maternity care and costs. Diabetes Care.
2013;36:1111–6.
2. Lydon-Rochelle MT, Holt VL, Cardenas V, Nelson JC, Easterling TR, Gardella C,
Callaghan WM. The reporting of pre-existing maternal medical conditions
and complications of pregnancy on birth certificates and in hospital
discharge data. Am J Obstet Gynecol. 2005;193:125–34.
3. Devlin HM, Desai J, Walaszek A. Reviewing performance of birth certificate
and hospital discharge data to identify births complicated by maternal
diabetes. Matern Child Health J. 2009;13:660–6.
4. Yasmeen S, Romano PS, Schembri ME, Keyzer JM, Gilbert WM. Accuracy of
obstetric diagnoses and procedures in hospital discharge data. Am J Obstet
Gynecol. 2006;194:992–1001.
5. Dietz PM, Vesco KK, Callaghan WM, Bachman DJ, Bruce FC, Berg CJ, England
LJ, Hornbrook MC. Postpartum screening for diabetes after a gestational
diabetes mellitus-affected pregnancy. Obstet Gynecol. 2008;112:868–74.
6. Hillier TA, Ogasawara KK, Pedula KL, Vesco KK. Markedly different rates of
incident insulin treatment based on universal gestational diabetes mellitus
screening in a diverse HMO population. Am J Obstet Gynecol. 2013;209:440.
e441–449.
7. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-
gynecologists. Number 30, September 2001 (replaces Technical Bulletin
Number 200, December 1994). Gestational diabetes. Obstet Gynecol. 2001;
98:525–38.
8. Practice Bulletin No 137. Gestational diabetes mellitus. Obstet Gynecol.
2013;122:406–16.
9. Carpenter MW, Coustan DR. Criteria for screening tests for gestational
diabetes. Am J Obstet Gynecol. 1982;144:768–73.
10. Atilano LC, Lee-Parritz A, Lieberman E, Cohen AP, Barbieri RL. Alternative
methods of diagnosing gestational diabetes mellitus. Am J Obstet Gynecol.
1999;181:1158–61.
11. Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR,
Hadden DR, McCance DR, Hod M, McIntyre HD, et al. Hyperglycemia and
adverse pregnancy outcomes. N Engl J Med. 2008;358:1991–2002.
12. National Institutes of Health consensus development conference statement.
Diagnosing gestational diabetes mellitus, March 4–6, 2013. Obstet Gynecol.
2013;122:358–69.
13. Daniells S, Grenyer BF, Davis WS, Coleman KJ, Burgess JA, Moses RG.
Gestational diabetes mellitus: is a diagnosis associated with an increase in
maternal anxiety and stress in the short and intermediate term? Diabetes
Care. 2003;26:385–9.
14. Hui AL, Sevenhuysen G, Harvey D, Salamon E. Stress and anxiety in women
with gestational diabetes during dietary management. Diabetes Educ. 2014;
40:668–77.
15. Naylor CD, Sermer M, Chen E, Sykora K. Cesarean delivery in relation to birth
weight and gestational glucose tolerance: pathophysiology or practice
style? Toronto Trihospital Gestational Diabetes Investigators. JAMA. 1996;
275:1165–70.
16. Mitrovic M, Stojic S, Tesic DS, Popovic D, Rankov O, Naglic DT, Paro JN, Pejin
R, Bulatovic S, Veljic MT, Zavisic BK. The impact of diabetes mellitus on the
course and outcome of pregnancy during a 5-year follow-up. Vojnosanit
Pregl. 2014;71:907–14.
17. Chen Y, Quick WW, Yang W, Zhang Y, Baldwin A, Moran J, Moore V, Sahai N,
Dall TM. Cost of gestational diabetes mellitus in the United States in 2007.
Popul Health Manag. 2009;12:165–74.
18. Getahun D, Fassett MJ, Jacobsen SJ. Gestational diabetes: risk of recurrence
in subsequent pregnancies. Am J Obstet Gynecol. 2010;203:467.e461–466.
19. Khambalia AZ, Ford JB, Nassar N, Shand AW, McElduff A, Roberts CL. Occurrence
and recurrence of diabetes in pregnancy. Diabet Med. 2013;30:452–6.
20. England L, Kotelchuck M, Wilson HG, Diop H, Oppedisano P, Kim SY, Cui X,
Shapiro-Mendoza CK. Estimating the Recurrence Rate of Gestational
Diabetes Mellitus (GDM) in Massachusetts 1998–2007: Methods and
Findings. Matern Child Health J. 2015;19:2303–13.
21. Vandorsten JP, Dodson WC, Espeland MA, Grobman WA, Guise JM, Mercer
BM, Minkoff HL, Poindexter B, Prosser LA, Sawaya GF, et al. NIH consensus
development conference: diagnosing gestational diabetes mellitus. NIH
Consens State Sci Statements. 2013;29:1–31.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Nicklas et al. BMC Pregnancy and Childbirth  (2017) 17:11 Page 6 of 6
